نتایج جستجو برای: cytogenetic

تعداد نتایج: 12450  

Journal: :Journal of Korean Medical Science 1992

Journal: :The Japanese Journal of Genetics 1962

2013
Akbar Safaei Jahanbanoo Shahryari Mohamad Reza Farzaneh Narjes Tabibi Marzieh Hosseini

BACKGROUND Acute lymphoblastic leukemia (ALL) is the sixth most common malignancy in Iran. Cytogenetic analysis of leukemic blasts plays an important role in classification and prognosis in ALL patients. The purpose of this study was to define the frequency of chromosomal abnormalities of ALL patients in adults and children in Fars province, Iran. METHODS In this cross-sectional study, we eva...

2010
Ji Hyun Lee Kyung A Kwon Suee Lee Sung Yong Oh Sung-Hyun Kim Hyuk-Chan Kwon Jin-Yeong Han Moo-Kon Song Joo-Seop Chung Ho Sup Lee Yang Soo Kim Sang-Min Lee Young-Don Joo Hyo-Jin Kim

BACKGROUND Cytogenetic abnormalities (CAs) have been reported frequently in patients with otherwise typical aplastic anemia (AA), but their implications in the prognosis and in the evolution to hematologic malignancies are controversial. METHODS We retrospectively analyzed 127 adult AA patients who had successful cytogenetic analysis at initial diagnosis. RESULTS The patients were classifie...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Ilaria Iacobucci Giuseppe Saglio Gianantonio Rosti Nicoletta Testoni Fabrizio Pane Marilina Amabile Angela Poerio Simona Soverini Simona Bassi Daniela Cilloni Renato Bassan Massimo Breccia Francesco Lauria Barbara Izzo Serena Merante Francesco Frassoni Stefania Paolini Enrico Montefusco Michele Baccarani Giovanni Martinelli

PURPOSE Most patients with chronic-phase chronic myeloid leukemia (CML) who receive imatinib achieve a complete cytogenetic remission (CCgR) and low levels of BCR-ABL transcripts. CCgR is durable in the majority of patients but relapse occurs in a subset. EXPERIMENTAL DESIGN To determine the potential of quantitative reverse transcription-PCR of BCR-ABL to predict cytogenetic relapse, we seri...

Journal: :JPMA. The Journal of the Pakistan Medical Association 2004
M Usman G N Kakepoto S N Adil R Sajid S Arain M Khurshid

OBJECTIVE To evaluate the response of Imatinib mesylate in patients with myeloid leukemia in chronic accelerated and blast phase. PATIENTS AND METHODS Eleven patients with established diagnosis of chronic myeloid leukemia were treated with Imatinib mesylate. Adverse events were documented with regular follow ups. Hematological and cytogenetic responses were assessed according to established c...

2013
Yuet-Meng Chin Puteri J Noor Azli Ismail Mohd Fadly Md Ahid Zubaidah Zakaria

Cytogenetic abnormalities at diagnosis are important prognostic indicators in acute myeloid leukemia (AML). AML is categorized into 3 risk groups according to cytogenetic abnormalities; favorable, intermediate, and unfavorable. A new cytogenetic risk group called the monosomal karyotype (MK) had been identified in AML in the unfavorable cytogenetic risk group. The MK was reported to be associat...

2013
Tolo Diebkilé Aïssata Duni Sawadogo Clotaire Nanho Boidy Kouakou N'dogomo Meité N'Dhatz Emeuraude Ayémou Roméo Sekongo Yassongui Mamadou Paul Kouéhion Konan Mozart Gustave Koffi Ibrahima Sanogo

Imatinib mesylate provides good results in the treatment of CML in general. But what about the results of this treatment in CML associated with additional cytogenetic abnormalities at diagnosis among black Africans? For this, we retrospectively studied 27 cases of CML associated with additional cytogenetic abnormalities, diagnosed in the department of clinical hematology of the University Hospi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید